Pfizer to discontinue twice-daily weight loss pill due to high rates of adverse side effects
CNBC· 11 小時前The drugmaker observed high rates of adverse side effects, which were mostly mild and ...
Why Pfizer's latest stumble in the obesity market is a boon for Eli Lilly
CNBC· 4 小時前Pfizer said Friday it will discontinue its twice-daily weight-loss pill, danuglipron, after ...
Pfizer drops twice-daily version of obesity pill over side effects
Reuters· 6 小時前Pfizer (PFE.N) said on Friday it would not advance a twice-daily version of oral weight-loss ...
With or without loan forgiveness, fewer students are enrolling in college, questioning the ...
CNBC· 7 小時前Nationwide, enrollment has lagged since the start of the Covid-19 pandemic, when a significant ...
Deion Sanders Named SI Sportsman Of The Year Amid Cloud Of Controversy
Forbes· 17 小時前Deion Sanders and Sports Illustrated (SI) have been the subject of much public discourse over ...
Fed Chair Powell calls talk of cutting rates 'premature' and says more hikes could happen
CNBC· 6 小時前Federal Reserve Chairman Jerome Powell on Friday pushed back on market expectations for ...
Powell says Fed to move 'carefully' on interest rates with risks 'more balanced'
Reuters· 6 小時前The risks of the Federal Reserve moving too far with interest rate hikes, and slowing the ...
NYC minimum wage for delivery drivers upheld by appeals court
Reuters· 7 小時前A New York state appeals court has turned away a challenge by Uber Technologies Inc and other ...
Pfizer Shares Drop After Axing Twice-Daily Weight-Loss Pill
Bloomberg· 11 小時前Pfizer Inc. is dropping development of an experimental weight-loss pill due to side effects, a ...
Weight-Loss Drugs Are a Gold Mine, and Just as Elusive
Bloomberg· 5 小時前On Friday, Pfizer Inc. announced that it’s dropping development of an experimental weight-loss ...
